Abstract PO3-06-03: Overall Survival and Disease Interval Among Breast Cancer Subtypes in Patients with Brain Metastasis

Authors

Asis Shrestha
Sugam Gouli, Rochester Regional HealthFollow
Sujan Niraula
Ramandeep Babbra
Niraj Neupane, Rochester Regional HealthFollow
Sarah Stanford
Myla Strawderman
Zeni Kharel, Rochester Regional HealthFollow
Huina Zhang
Sara Hardy
Nimish Mohile
Carey Anders
David Hicks
Ruth O'Regan
Ajay Dhakal

Department

Medicine

Additional Department

Internal Medicine

Document Type

Conference Proceeding

Publication Title

Cancer Research

Conference Name

San Antonio Breast Cancer Symposium

Conference Date

2023-12-05 - 2023-12-09

First Page

PO3-06-03

DOI

10.1158/1538-7445.SABCS23-PO3-06-03

Volume

84

Issue

9_Supplement

Publication Date

5-1-2024

Recommended Citation

Shrestha, A., Gouli, S., Niraula, S., Babbra, R., Neupane, N., Stanford, S., Strawderman, M., Kharel, Z., Zhang, H., Hardy, S., Mohile, N., Anders, C., Hicks, D., O'Regan, R., & Dhakal, A. (2024). Abstract PO3-06-03: Overall Survival and Disease Interval Among Breast Cancer Subtypes in Patients with Brain Metastasis. Cancer Research, 84 (9_Supplement), PO3-06-03. https://doi.org/10.1158/1538-7445.SABCS23-PO3-06-03